Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,047.40
+11.190.55%
Number of Gainers:685
Number of Losers:320
Number of Flat:15
PE:- -
High:2,051.98
Open:2,036.29
Low:2,036.19
Close:2,036.19
Volume:3.08B
Turnover:392.82B
Market Cap:97.78T
Float Cap:91.52T

Loading ...

TransDigm Price Target Cut to $1400.00/Share from $1525.00 by BMO Capital

Dow Jones
·
Sep 29

Microsoft (MSFT) Is No Longer Mispriced, but It Still Looks Undervalued

TIPRANKS
·
Sep 29

Nvidia Stock Gains as Anthropic Locks In 2.5GW of AI Infrastructure

TIPRANKS
·
Sep 29

Immunovia Launches SEK 63 Million Unit Rights Issue with Attached Warrants

Reuters
·
Sep 29

Diagnos Seeks U.S. FDA Clarity on AI-Powered CARA Eye Screening System

TIPRANKS
·
Sep 29

Tesla Stock (NASDAQ:TSLA) Slides As Roadster Demo May Face Weather Delay

TIPRANKS
·
Sep 29

Pinterest put volume heavy and directionally bearish

TIPRANKS
·
Sep 29

Southwest Airlines Price Target Cut to $50.00/Share from $60.00 by BMO Capital

Dow Jones
·
Sep 29

FTSE 100 Index Ends 0.10% Lower at 10684.88

Dow Jones
·
Sep 29

Citi Token Services Expands Global Footprint into Japan, UAE

Reuters
·
Sep 29

US Equity Indexes Fall in Midday Trading

MT Newswires Live
·
Sep 29

Oil Futures Pare Gains, US Crude Turns Negative as Qatari Mediators Hold Talks with Iran and US on Possible Peace Deal

THOMSON REUTERS
·
Sep 29

Global Markets-Stocks Fall, Squeezed by Rising Oil Prices and Treasury Yields

Reuters
·
Sep 29

European Shares End Flat as Bond Selloff Offsets UK Homebuilder Gains

Deep News
·
Sep 29

McDonald's Estimates Lowered to Reflect New Financial Targets, Morgan Stanley Says

MT Newswires Live
·
Sep 29

ADC SIIC H1 FY26 Net Loss Narrows to EUR 265,000; Net Rental Income Falls 20.95% to EUR 332,000

Reuters
·
Sep 29

BeOne Medicines Advances BGB-58067 Tablet Study, Sharpening Early-Stage Investor Focus

TIPRANKS
·
Sep 29

Octopus AIM VCT Estimates NAV at 40.1 Pence/share as at Sept. 21 2026

Reuters
·
Sep 29

AstraZeneca Advances Fixed-Dose Cholesterol Combo With Completed Phase I Bioavailability Study

TIPRANKS
·
Sep 29

Nvidia is Right: Its Stock is a Bargain

Dow Jones
·
Sep 29